Advance Search | Bentham Science

Conformationally Constrained Peptides as Protein Tyrosine Kinase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 20 Year: 2012 Page: 2852-2866
Author(s): Rakesh K. Tiwari,Keykavous Parang

Small Molecule Tyrosine Kinase Inhibitors: The New Dawn for Cancer Therapy

Journal: Letters in Drug Design & Discovery
Volume: 9 Issue: 1 Year: 2012 Page: 84-125
Author(s): Malleshappa N. Noolvi, Harun M. Patel

The 2010 Patent Landscape for Spleen Tyrosine Kinase Inhibitors+

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 6 Issue: 2 Year: 2012 Page: 97-120
Author(s): Alessandro F. Moretto,Christoph Dehnhardt,Neelu Kaila,Nikolaos Papaioannou,Atli Thorarensen

Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib

Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 15 Year: 2012 Page: 1649-1659
Author(s): Lale Erdem,Elisa Giovannetti,Leticia G Leon,Richard Honeywell,Godefridus J. Peters

Novel Patented Src Kinase Inhibitor

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 12 Year: 2012 Page: 1821-1829
Author(s): Xiao-Ling Lu,Xiao-Yu Liu,Xin Cao,Bing-Hua Jiao

Impact of Oncogenic Protein Tyrosine Phosphatases in Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2012 Page: 4-18
Author(s): Serge Hardy, Sofi G. Julien, Michel L. Tremblay

Synthesis of Cis-Fused Pyran Indolocarbazole Derivatives that Inhibit FLT3 Kinase and the DNA Damage Kinase, Checkpoint Kinase 1

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 3 Year: 2012 Page: 194-201
Author(s): Francoise M. Perron-Sierra, Nathalie Kucharkzyk, Celine Boucley, Christel Guyard-Daumas, Sophie Sciberras, Christine Fouache, Sabine Plantier, Aurelie Studeny, Celine Bossard, Patrick J. Casara, Roy M. Golsteyn

The Role of FLT3 Kinase as an AML Therapy Target

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 19 Year: 2012 Page: 2758-2765
Author(s): Michal Beffinger,Anna Skwarska

Anti-VEGF Strategies â from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 19 Year: 2012 Page: 2680-2701
Author(s): Grzegorz Korpanty,Elizabeth Smyth

Characteristics of Brain Tumor Stem Cells and the Rationale for Applying Tyrosine Kinase Inhibitors as Potential Targeting Agents

Journal: Recent Patents on Regenerative Medicine
Volume: 2 Issue: 3 Year: 2012 Page: 197-207
Author(s): Michael R. Mangum,Deepti Purohit,Ichiro Nakano

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "tyrosine kinase."